Matsakaicin Lesinurad CAS 1533519-84-4 Tsarkake>99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. shine babban kamfani na 4- (4-Cyclopropylnaphthalen-1-yl) -1H-1,2,4-Triazole-5(4H) -Thione (CAS: 1533519-84-4) tare da babban inganci, matsakaicin Lesinurad (CAS: 878672-00-5).Ruifu Chemical na iya samar da isar da saƙo na duniya, farashi mai gasa, kyakkyawan sabis, ƙanana da adadi mai yawa akwai.Sayi Lesinurad Intermediates,Please contact: alvin@ruifuchem.com
Sunan Sinadari | 4- (4-Cyclopropylnaphthalen-1-yl)-1H-1,2,4-Triazole-5(4H)-Thione |
Makamantu | 4- (4-Cyclopropylnaphthalen-1-yl) -4H-1,2,4-Triazole-3-Thiol;4- (4-Cyclopropyl-1-Naphthalenyl) -2,4-Dihydro-3H-1,2,4-Triazole-3-Thione;Lesinurad INT3;Lesinurad rashin tsarki 20 |
Matsayin Hannun jari | A Stock, Kasuwancin Kasuwanci |
Lambar CAS | 1533519-84-4 |
Tsarin kwayoyin halitta | Saukewa: C15H13N3S |
Nauyin Kwayoyin Halitta | 267.35 g/mol |
Wurin Tafasa | 435.2 ± 38.0 ℃ |
Yawan yawa | 1.41± 0.10 g/cm3 |
COA & MSDS | Akwai |
Asalin | Shanghai, China |
Kashi | Matsakaicin Lesinurad (CAS: 878672-00-5) |
Alamar | Ruifu Chemical |
Abubuwa | Ka'idojin dubawa | Sakamako |
Bayyanar | Kashe-Farin Foda | Kashe-Farin Foda |
Ruwa ta Karl Fischer | <0.50% | 0.10% |
Asara akan bushewa | <0.50% | 0.40% |
Ragowa akan Ignition | <0.50% | 0.15% |
Tsarkake / Hanyar Bincike | > 99.0% (HPLC) | 99.8% |
Infrared Spectrum | Daidai da Tsarin | Ya bi |
1H NMR Spectrum | Daidai da Tsarin | Ya bi |
Kammalawa | An gwada samfurin kuma ya bi ƙayyadaddun da aka bayar |
Kunshin:Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye akwati sosai kuma a adana a wuri mai sanyi, bushe (2 ~ 8 ℃) da ma'ajin da ke da isasshen iska daga abubuwan da ba su dace ba.Kare daga haske da danshi.
Jirgin ruwa:Isar da shi zuwa duniya ta iska, ta FedEx / DHL Express.Bayar da isarwa cikin sauri kuma abin dogaro.
Yadda ake siya?Da fatan za a tuntuɓiDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Kwarewar Shekaru 15?Muna da fiye da shekaru 15 na gwaninta a cikin ƙira da fitarwa na matsakaicin matsakaicin magunguna masu inganci ko sinadarai masu kyau.
Manyan Kasuwanni?Sayarwa zuwa kasuwannin cikin gida, Arewacin Amurka, Turai, Indiya, Koriya, Jafananci, Australia, da sauransu.
Fa'idodi?Babban inganci, farashi mai araha, sabis na ƙwararru da tallafin fasaha, bayarwa da sauri.
inganciTabbaci?Tsananin kula da ingancin inganci.Kayan aikin ƙwararru don bincike sun haɗa da NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, gwajin ƙayyadaddun ƙwayoyin cuta, da sauransu.
Misali?Yawancin samfurori suna ba da samfurori kyauta don ƙima mai kyau, farashin jigilar kaya ya kamata a biya ta abokan ciniki.
Binciken Masana'antu?Ma'aikata duba maraba.Da fatan za a yi alƙawari a gaba.
MOQ?Babu MOQ.Karamin tsari abin karɓa ne.
Lokacin Bayarwa? Idan cikin hannun jari, garantin isar da kwana uku.
Sufuri?By Express (FedEx, DHL), ta Air, ta Teku.
Takardu?Bayan sabis na tallace-tallace: COA, MOA, ROS, MSDS, da dai sauransu za a iya ba da su.
Tsarin al'ada?Zai iya ba da sabis na haɗawa na al'ada don dacewa da buƙatun bincikenku.
Sharuɗɗan Biyan kuɗi?Za a fara aiko da daftari na Proforma bayan tabbatar da oda, an rufe bayanan bankin mu.Biya ta T/T (Telex Transfer), PayPal, Western Union, da dai sauransu.
L-Phenylalanine (H-Phe-OH) (CAS: 63-91-2) ana amfani dashi azaman tsaka-tsaki a cikin kirar Lesinurad (CAS: 878672-00-5).Lesinurad wani zaɓi ne mai hana uric acid reabsorption wanda ake amfani dashi tare da wasu wakilai a cikin maganin gout.Lesinurad (sunan mai suna Zurampic) shine farkon mai hana uric acid reabsorption (SURI) wanda FDA ta amince da shi.Yana aiki ta hanyar hana mai jigilar urate, URAT1, wanda ke da alhakin yawancin reabsorption na uric acid.Lesinurad shine mai hana jigilar jigilar urate don kula da hyperuricemia da ke hade da gout a cikin marasa lafiya waɗanda ba su cimma burin maganin uric acid tare da mai hana xanthine oxidase kadai ba.Ya sami amincewar FDA a ranar 22 ga Disamba, 2015. Hukumar Tarayyar Turai ta ba da izinin tallace-tallace mai aiki a cikin Tarayyar Turai a kan 18 Fabrairu 2016.